HGHSX Mutual Fund

NAV$47.11

Fund Essentials - as of Jan 31, 2026

Net Assets
$9M
Expense Ratio
1.31%
Dividend Yield (Current)
3.05%
Holdings
84
Inception Date
Dec 22, 2006
Fund Family
Hartford Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+7.43%
1 Year+32.43%
3 Year+8.58%
5 Year+5.20%
10 Year+13.06%

Asset Allocation

Stocks: 99.68%
Bonds: 0.19%
Cash: 0.14%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co13.12%
MRKMerck & Company Inc5.74%
JNJJohnson & Johnson5.07%
UNHUnitedhealth Group Incorporated4.64%
ABBVAbbvie Inc3.84%
Top 10 Concentration: 47.48%Report Date: Jan 31, 2026
Download all 84 holdings for HGHSX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.05%
Frequency
Annually
Latest Distribution
$4.37
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how HGHSX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

HGHSX Mutual Fund Overview

HGHSX Mutual Fund (The Hartford Healthcare Fund Cl R4) is managed by Hartford Funds with $8.5M in net assets. HGHSX expense ratio is 1.31%, holding 84 positions across sectors including Health Care, Unknown, Financials. Inception date: 2006-12-22.

HGHSX performance shows a YTD return of 7.43%. The 1-year return is 32.43% and the 5-year return is 5.20%. HGHSX dividend yield stands at 3.05%, paid annually.

HGHSX top holdings include Eli Lilly & Co (13.1%), Merck & Company Inc (5.7%), Johnson & Johnson (5.1%), Unitedhealth Group Incorporated (4.6%), Abbvie Inc (3.8%). View all HGHSX holdings, sector breakdown, or dividend history.

HGHSX can be compared against other funds using the overlap calculator or side-by-side comparison tool. HGHSX alternatives are available via the screener, along with tax-loss harvesting opportunities.